21 completed, 4 unknown, 1 enrolling by invitation, 1 recruiting. 7 Not applicable, 7 Phase 2, 6 Phase 1, 3 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 7 |
| Phase 2 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Phase 1 | 6 | Completed 5, Unknown 1 |
| Phase 3 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow Foodborne Diseases: new trials by email Literature Review of Foodborne Diseases trials Research Report on Foodborne Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Health Impacts of Street Vended Fruits Fresh-Cut Guava Consumption, Fresh-Cut Pineapple Consumption, Fresh-Cut Watermelon Consumption - Gastrointestinal Diseases, Foodborne Diseases | Not applicable | Completed | Bangladesh Agricultural University | 639 | 2025-03-06 | 2025-03-20 |
| Meatsafe Food Storage and Diarrhea Prevention Trial in Urban Bangladesh Meatsafe Food Storage Cabinet - Diarrhea | Not applicable | Completed | University of California, Berkeley | 290 | 2024-08-11 | 2026-01-12 |
| Study of the Drug B11-FC (Botulism Treatment) B11-FC, Botulinum neurotoxin type A, Placebo - Botulism | Phase 1 / Phase 2 | Unknown | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 40 | 2024-08-01 | 2024-08-30 |
| Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG® rBV A/B - Botulism | Phase 2 | Completed | California Department of Public Health | 25 | 2024-07-09 | 2026-07-30 |
| Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA Amifampridine - Botulism, Iatrogenic Botulism | Phase 1 | Completed | Wake Forest University Health Sciences | 21 | 2023-09-15 | 2025-02-03 |
| Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis Botulinum toxin, Standard-of-care corticosteroid injections - Carpometacarpal Sprain, Thumb Sprain | Phase 3 | Recruiting | Rhode Island Hospital | 50 | 2023-08-27 | 2024-11-20 |
| Prevention of Paralytic Shellfish Poisoning in Subsistence Shellfish Harvest Communities of Southeast Alaska Middle school education program - Shellfish Poisoning, Paralytic | Not applicable | Completed | University of Alabama at Birmingham | 50 | 2022-03-01 | 2025-10-03 |
| Trends of Acute Intoxication in Poison Control Centre Poison - Poison Drug, Poison;Medicinal;Wrong Drug | Unknown | MTI University | 10000 | 2021-10-01 | 2021-10-28 | |
| Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome 3mg AZ-010, 1mg AZ010, Staccato Placebo - Cyclic Vomiting Syndrome | Phase 2 | Completed | Alexza Pharmaceuticals, Inc. | 150 | 2021-02-05 | 2025-06-11 |
| Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke Patients Botulinum toxin injection - Stroke, Spasticity, Muscle | Unknown | National Taiwan University Hospital | 100 | 2020-09-01 | 2020-09-16 | |
| Good Hygiene Practice Interventions for Safer Pork at Traditional Markets in Cambodia Improve hygiene practice of pork sellers - Food Borne Diseases, Food Safety | Not applicable | Completed | The International Livestock Research Institute (ILRI) | 360 | 2020-06-30 | 2021-09-02 |
| Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects G03-52-01, Placebo - Healthy | Phase 1 | Completed | Alachua Government Services, Inc. | 40 | 2020-06-01 | 2024-10-04 |
| Knowledge,Attitude and Practice of Food Handleres About Food Safety nasal swap - Food Borne Diseases | Unknown | Assiut University | 276 | 2020-04-01 | 2020-03-18 | |
| Mapping the Health Status of the Population of French Polynesia: the MATAEA Project Questionnaire, Physical measurements, Biological samples - Non Communicable Diseases, Microbiome | Not applicable | Completed | Institut Louis Malardé | 1942 | 2019-11-04 | 2023-11-18 |
| Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG® rBV A/B - Botulism | Phase 2 | Completed | California Department of Public Health | 32 | 2019-03-07 | 2021-10-19 |
| A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults NTM-1633, Placebo - Botulism | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 24 | 2018-09-25 | 2022-06-22 |
| Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B rBV A/B, Placebo (USP sterile saline for injection) - Botulism | Phase 3 | Withdrawn | DynPort Vaccine Company LLC, A GDIT Company | 2017-10-01 | 2018-12-04 | |
| Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632 NTM-1632, Placebo - Botulism | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 24 | 2016-08-01 | 2018-10-29 |
| BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin BAT - Botulism | Completed | Emergent BioSolutions | 162 | 2014-10-01 | 2024-03-15 | |
| BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients Blood sample collection - Botulism | Phase 4 | Enrolling by invitation | Emergent BioSolutions | 10 | 2014-10-01 | 2026-01-16 |
Showing 20 of 29. Sign in to see all of them.
Botulism (19) · Communicable Diseases (2) · Drug-Related Side Effects and Adverse Reactions (2) · Escherichia coli Infections (2) · Poisoning (2) · Abdominal Pain (1) · Bacterial Infections (1) · Ciguatera Poisoning (1) · Clostridium Infections (1) · Diarrhea (1) · Familial cyclic vomiting syndrome (1) · Favism (1) · Gastrointestinal Diseases (1) · Glucosephosphate Dehydrogenase Deficiency (1)
Chemically-Induced Disorders (29) · Poisoning (27) · Infections (22) · Bacterial Infections and Mycoses (21) · Bacterial Infections (20) · Gram-Positive Bacterial Infections (20) · Nervous System Diseases (20) · Neuromuscular Diseases (19) · Neuromuscular Junction Diseases (19) · Neurotoxicity Syndromes (19) · Clostridium Infections (18) · Pathological Conditions, Signs and Symptoms (6) · Pathologic Processes (3) · Signs and Symptoms (3)
Botulinum Antitoxin (3) · Amifampridine (2) · Botulinum Toxins (2) · Botulinum Toxins, Type A (2) · Injections (1) · Poisons (1) · Primaquine (1) · Silybin (1) · Surveys and Questionnaires (1) · botulism immune globulin (1)
California Department of Public Health (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Department of Medical Services Ministry of Public Health of Thailand (2) · Emergent BioSolutions (2) · Alachua Government Services, Inc. (1) · Alexza Pharmaceuticals, Inc. (1) · Assiut University (1) · Bangladesh Agricultural University (1) · California Department of Health Services (1) · Centre Hospitalier Universitaire, Amiens (1) · Centre Hospitalier le Mans (1) · DynPort Vaccine Company LLC, A GDIT Company (1) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (1) · Institut Louis Malardé (1) · MTI University (1)
United States (14) · Bangladesh (2) · Egypt (2) · France (2) · Thailand (2) · Cambodia (1) · French Polynesia (1) · Taiwan (1)
Subsai Kongsaengdao, M.D. (2) · Cassandra Key, MD (1) · Christophe Guitton, MD (1) · Delia Randolph, PhD (1) · George A Saviolakis, M.D., Ph.D. (1) · Huey-Wen Liang, MD PHD (1) · James B Caress, MD (1) · Jason S Richardson, Ph.D. (1) · Larry Carter, PhD (1) · Maha Wahdan (1) · Mariam Roushdy, MD (1) · Md. Ariful Islam, PhD (1) · Shon A Remich (1)
PMID 17051488, PMID 24007658, PMID 29475762, PMID 31209461, PMID 33875433, PMID 38455935, PMID 41574333, PMID 42275407
R01ES029165 (1)